Envafolimab drug page Clinical trials

Trials with Envafolimab

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

9Trials
3Recruiting
1Countries
1.196Planned patients

Showing 1–3 of 3

Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.
Finished Phase 2 33 patients NCT06060704

The goal of this single-arm study is to evaluate the efficacy and safety of Envafolimab combined with Trifluridine/Tipiracil and Bevacizumab in the treatment of metastatic colorectal cancer patients who are refractory or intolerant to stan…

China Nov 2023 – Sept 2025 Interventional
Combined with: Bevacizumab
Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer
Finished Phase 2 55 patients NCT06014372

There exists substantial evidence suggesting that patients diagnosed with MSI-H/dMMR colorectal cancer can derive benefits from immunotherapy in the management of advanced colorectal cancer. In cases of locally advanced colorectal cancer e…

China Jul 2023 – Jul 2026 Interventional
Combined with: CapecitabineOxaliplatin
Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer
Finished 38 patients NCT05645094

This is a single center, prospective, single arm clinical trial to evaluate the efficacy and safety of Envafolimab as a neoadjuvant therapy for resectable and locally advanced dMMR or MSI-H rectal cancer.

Jan 2023 – Jun 2026 Observational

Where the recruiting trials are